Overview
Neuralign has developed a digital platform that uses standardized neuropsychological assessments and EEG biomarkers to identify and treat reading and learning disabilities in children. Their Lokomat-compatible neurofeedback and cognitive training tools are deployed in schools and clinics.
More in Neurodiagnostics
Latest industry news
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-09-23 · Policy
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Company details
Category
🔬 Neurodiagnostics
Location
Toronto, Canada
Funding
Series A · $8M
Website
neuralign.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →